USPTO serial 88960228
OPPORTUNITY FOR TESTING INDEX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 26, 2021
- Examiner
- GUTTADAURO, JULIE MARIE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with OPPORTUNITY FOR TESTING INDEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MARGARET M. POWERS
MARGARET M. POWERS SHAY GLENN LLP2929 CAMPUS DRIVE, STE 225SAN MATEO, CA 94403UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic testing materials in the nature of reagents for medical use; Medical diagnostic reagents and assays for testing of body fluids; Reagents for use in diagnostic tests for medical purposes | ACTIVE | — |
| 009 | Downloadable computer software for use in relation to medicine and pharmaceutical research and development services for data management, data analysis, data manipulation; downloadable computer software used to connect laboratory networks and diagnostic and pharmaceutical companies; downloadable computer software used to analyse data in the field of medicine and pharmaceutical testing, research and development; downloadable computer software for use in relation to business networking and content management in the field of medicine and pharmaceutical testing, research and development; downloadable computer software applications for data management and visualisation, for generating reports, charts and dashboards in the field of medicine and pharmaceutical research and development | ACTIVE | — |
| 042 | Pharmaceutical drug development services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; research relating to medicines; testing of pharmaceuticals; computer aided diagnostic testing services, namely, computer-aided diagnostic product testing; design and development of medical diagnostic apparatus; research and development in the field of diagnostic preparations; design and development of computer databases; software design services relating to data processing test tools; provision of information and data relating to medical and veterinary research and development; technical data analysis services, namely, data analysis for medicine and pharmaceutical testing, research and development purposes; information, advice and consultancy in relation to all the aforesaid services, namely, providing information in the field of research and development of pharmaceutical preparations; Software as a service (SAAS) services featuring software in relation to data management, data analysis, data manipulation, and medicine and pharmaceutical testing, research and development services; Software as a service (SAAS) services featuring software in relation to communication between laboratory networks and diagnostic and pharmaceutical companies; Software as a service (SAAS) services featuring software in relation to data management and visualisation, for generating reports, charts and dashboards; Platform as a service (PAAS) featuring computer software platforms for use in relation to data management, data analysis, data manipulation, and medicine and pharmaceutical testing, research and development services; Platform as a service (PAAS) featuring computer software platforms for use in relation to communication between laboratory networks and diagnostic and pharmaceutical companies; Platform as a service (PAAS) featuring computer software platforms for use in relation to data management and visualisation for generating reports, charts and dashboards; information, advice and consultancy in relation to all the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Diaceutics plc
- Other trademarks owned by Diaceutics plc
- Other trademarks owned by Diaceutics plc
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named OPPORTUNITY FOR TESTING INDEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 26, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 10, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 10, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 21, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 7, 2021 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 7, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 24, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 24, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 24, 2021 | ALIE | ASSIGNED TO LIE | — |
| Apr 12, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 18, 2021 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Mar 18, 2021 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Mar 18, 2021 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| Mar 18, 2021 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Sep 21, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 21, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 21, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 5, 2020 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jul 8, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 15, 2020 | NWAP | NEW APPLICATION ENTERED | — |